The role of gut microbiota and diet has become a major concern for the health of Alzheimer’s disease (AD) individuals. The literatures shows that the microbiome composition has been linked to neurodegenerative disease and plays a critical role in the gut and brain axis. Microbial fermentation may release microbial metabolites that release short chain fatty acids such as butyric acid that has a major influence on the gut brain axis with effects on brain amyloid beta levels and plaque deposition. Researchers indicate that the understanding how the gut microbes interact with drugs and regulate gut microbes may improve the therapeutic effects and clinical outcomes of drugs with relevance to neurodegenerative diseases. The use of specific drugs may have major impact on the composition and metabolic function of gut microbiota metabolites and therapeutics for AD. Research is required on various drugs to assess drug-microbiota interactions on gram negative versus gram positive bacteria to reduce microbial metabolites such as toxic bacterial lipopolysaccharide levels in the plasma and brain with relevance to Alzheimer’s disease.
RELEVANT REFERENCES:
1. Sharma, A and IJ Martins. The role of Microbiota in the pathogenesis of Alzheimer’s disease. Acta Scientific Nutritional Health. 7.7 (2023): 108-118.
2. Vich Vila, A., Collij, V., Sanna, S. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11, 362 (2020).
3. Wan Y, Zuo T. Interplays between drugs and the gut microbiome. Gastroenterol Rep (Oxf). 2022 Apr 8;10:goac009.
4. Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut 2020;69:1510-1519.
5. Pant A, Maiti TK, Mahajan D, Das B. Human Gut Microbiota and Drug Metabolism. Microb Ecol. 2023 Jul;86(1):97-111.
6. Misera A, Łoniewski I, Palma J, Kulaszyńska M, Czarnecka W, Kaczmarczyk M, Liśkiewicz P, Samochowiec J and Skonieczna-Żydecka K (2023) Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review. Front. Microbiol. 14:1125022.
7. Zhao, Q., Chen, Y., Huang, W. et al. Drug-microbiota interactions: an emerging priority for precision medicine. Sig Transduct Target Ther 8, 386 (2023).
8. Wang, S.; Ju, D.; Zeng, X. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era. Biomedicines 2024, 12, 194.
Impact of Drugs on Gut Microbiota
1. Antibiotics:
- Alteration of Microbiota Composition: Antibiotics can significantly disrupt the gut microbiota, leading to reduced diversity and changes in the relative abundance of bacterial species. This can have long-term effects on the gut ecosystem.
- Functional Impacts: These changes can impact metabolic functions such as bile acid metabolism, short-chain fatty acid production, and immune modulation.
2. Metformin:
- Diabetes and Metabolic Health: Metformin, a common diabetes medication, has been shown to alter gut microbiota composition, increasing the abundance of beneficial bacteria such as Akkermansia muciniphila. These changes are believed to contribute to its beneficial effects on glucose metabolism.
3. Proton Pump Inhibitors (PPIs):
- Gastrointestinal Health: PPIs, used for reducing stomach acid, can also alter gut microbiota. They have been associated with decreased microbial diversity and increased risk of Clostridium difficile infections.
4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):
- Inflammation and Gut Health: NSAIDs can affect gut microbiota composition and increase intestinal permeability, potentially leading to dysbiosis and gut inflammation.
Gut Microbiota and Alzheimer's Disease
1. Microbiota-Gut-Brain Axis:
- The gut-brain axis refers to the bidirectional communication between the gut and the brain. Gut microbiota can influence brain function through various mechanisms, including modulation of the immune system, production of neuroactive compounds, and regulation of the gut barrier.
2. Inflammation and Neurodegeneration:
- Chronic systemic inflammation, often linked to gut dysbiosis, is a known risk factor for neurodegenerative diseases like AD. Altered gut microbiota composition can lead to increased gut permeability and systemic inflammation, which might exacerbate neuroinflammation and AD pathology.
3. Specific Bacterial Strains and AD:
- Certain bacterial strains have been implicated in the development or prevention of AD. For instance, beneficial bacteria producing short-chain fatty acids (e.g., butyrate) have neuroprotective effects, whereas some pathogenic bacteria might contribute to amyloid plaque formation and neurodegeneration.
Therapeutics for Alzheimer’s Disease
Given the influence of gut microbiota on systemic inflammation and brain health, modulating the gut microbiome is being explored as a therapeutic strategy for AD.
1. Probiotics and Prebiotics:
- These can promote the growth of beneficial bacteria and have shown promise in improving cognitive function and reducing neuroinflammation in preclinical models of AD.
2. Fecal Microbiota Transplantation (FMT):
- FMT involves transferring gut microbiota from a healthy donor to a recipient. Preliminary studies suggest that FMT can restore gut microbiota balance and might have beneficial effects on neuroinflammation and cognitive function in AD.
3. Dietary Interventions:
- Diets rich in fiber and polyphenols can positively modulate gut microbiota, potentially leading to reduced inflammation and improved brain health. The Mediterranean diet, for example, has been associated with a lower risk of AD.
4. Antibiotics and Gut-Brain Therapy:
- Specific antibiotics might be used to target pathogenic bacteria contributing to neuroinflammation. However, this approach requires careful consideration due to the potential for broad-spectrum antibiotics to disrupt beneficial microbiota.
- Badges
- Science topic
- Similar topics
- Psychology